Found: 26
Select item for more details and to access through your institution.
Allelic imbalance in CALR somatic mutagenesis.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 6, p. 1431, doi. 10.1038/leu.2015.3
- By:
- Publication type:
- Article
Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 1, p. 20, doi. 10.1038/leu.2014.250
- By:
- Publication type:
- Article
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1874, doi. 10.1038/leu.2013.163
- By:
- Publication type:
- Article
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 4, p. 716, doi. 10.1038/leu.2011.258
- By:
- Publication type:
- Article
Rare germline variants in regions of loss of heterozygosity may influence clinical course of hematological malignancies.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 7, p. 1290, doi. 10.1038/leu.2010.99
- By:
- Publication type:
- Article
The ‘GGCC’ haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 10, p. 1924, doi. 10.1038/leu.2009.110
- By:
- Publication type:
- Article
Dasatinib inhibits progenitor cell proliferation from polycythaemia vera.
- Published in:
- European Journal of Clinical Investigation, 2008, v. 38, n. 8, p. 578, doi. 10.1111/j.1365-2362.2008.01982.x
- By:
- Publication type:
- Article
Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS.
- Published in:
- European Journal of Clinical Investigation, 2008, v. 38, n. 1, p. 53, doi. 10.1111/j.1365-2362.2007.01903.x
- By:
- Publication type:
- Article
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group.
- Published in:
- 2007
- By:
- Publication type:
- Correction notice
Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 3, p. 227, doi. 10.1111/j.1600-0609.2006.00807.x
- By:
- Publication type:
- Article
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group.
- Published in:
- Leukemia (08876924), 2007, v. 21, n. 2, p. 277, doi. 10.1038/sj.leu.2404473
- By:
- Publication type:
- Article
Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
- Published in:
- Leukemia (08876924), 2004, v. 18, n. 11, p. 1879, doi. 10.1038/sj.leu.2403518
- By:
- Publication type:
- Article
Endothelial dysfunction in patients with polycythaemia vera.
- Published in:
- British Journal of Haematology, 2001, v. 115, n. 2, p. 354, doi. 10.1046/j.1365-2141.2001.03092.x
- By:
- Publication type:
- Article
Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?
- Published in:
- British Journal of Haematology, 2001, v. 112, n. 3, p. 783, doi. 10.1046/j.1365-2141.2001.02608.x
- By:
- Publication type:
- Article
Ineffectiveness of interferon-γ in the treatment of idiopathic myelofibrosis: a pilot study.
- Published in:
- Annals of Hematology, 2001, v. 80, n. 2, p. 79, doi. 10.1007/s002770000231
- By:
- Publication type:
- Article
Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Fludarabine therapy in Waldenström's macroglobulinemia.
- Published in:
- 2000
- By:
- Publication type:
- journal article
The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera.
- Published in:
- European Journal of Haematology, 1999, v. 62, n. 1, p. 27, doi. 10.1111/j.1600-0609.1999.tb01110.x
- By:
- Publication type:
- Article
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Interferon alpha in the therapy of multiple myeloma.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Successful re-treatment of an anti-interferon resistant polycythaemia vera patient with lymphoblastoid interferon-αN1 and in vitro studies on the specificity of the antibodies.
- Published in:
- British Journal of Haematology, 1994, v. 86, n. 1, p. 216, doi. 10.1111/j.1365-2141.1994.tb03283.x
- By:
- Publication type:
- Article
Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha.
- Published in:
- Clinical & Experimental Immunology, 1992, v. 90, n. 3, p. 363
- By:
- Publication type:
- Article
Treatment with Recombinant Interferon-Alpha-2C: Multiple Myeloma and Thrombocythaemia in Myeloproliferative Diseases.
- Published in:
- Oncology, 1985, v. 42, n. S1, p. 19, doi. 10.1159/000226080
- By:
- Publication type:
- Article